Current Science : Impact Factor & More
eISSN: 0011-3891pISSN: 0011-3891
Share this on:
Key Metrics
CiteScore 
1.6
Impact Factor
< 5
SNIP
0.68
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Current Science
Current Science Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
Inspec 
SJR
| Overview | |
| Publisher | INDIAN ACAD SCIENCES |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 1932 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Science ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Science
Correction: Copy number amplification-induced overexpression of lncRNA LOC101927668 facilitates colorectal cancer progression by recruiting hnRNPD to disrupt RBM47/p53/p21 signaling.
- 1 Jul 2026
- Journal of experimental & clinical cancer research : CR
Decoding glioblastoma evolution and heterogeneity through mechanistic modeling: implications for clinical translation.
- 29 Jun 2026
- Journal of experimental & clinical cancer research : CR
HES1 inhibition overcomes CDK4/6 inhibitor resistance by targeting cancer stemness in lung adenocarcinoma
- 27 Jun 2026
- Journal of Experimental & Clinical Cancer Research
Reciprocal signaling-metabolic crosstalk between fibroblasts and tumor cells drives cetuximab tolerance in head and neck cancers.
- 24 Jun 2026
- Journal of experimental & clinical cancer research : CR
Correction: MTA1 promotes metastasis of MPM via suppression of E-cadherin
- 23 Jun 2026
- Journal of Experimental & Clinical Cancer Research : CR
Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancer.
- 23 Jun 2026
- Journal of experimental & clinical cancer research : CR
Correction: Copy number amplification-induced overexpression of lncRNA LOC101927668 facilitates colorectal cancer progression by recruiting hnRNPD to disrupt RBM47/p53/p21 signaling.
- 1 Jul 2026
- Journal of experimental & clinical cancer research : CR
Decoding glioblastoma evolution and heterogeneity through mechanistic modeling: implications for clinical translation.
- 29 Jun 2026
- Journal of experimental & clinical cancer research : CR
HES1 inhibition overcomes CDK4/6 inhibitor resistance by targeting cancer stemness in lung adenocarcinoma
- 27 Jun 2026
- Journal of Experimental & Clinical Cancer Research
Reciprocal signaling-metabolic crosstalk between fibroblasts and tumor cells drives cetuximab tolerance in head and neck cancers.
- 24 Jun 2026
- Journal of experimental & clinical cancer research : CR
Correction: MTA1 promotes metastasis of MPM via suppression of E-cadherin
- 23 Jun 2026
- Journal of Experimental & Clinical Cancer Research : CR
Targeting metabolic dependencies to reverse chemoradiotherapy resistance in colorectal cancer.
- 23 Jun 2026
- Journal of experimental & clinical cancer research : CR
FAQs on Current Science
How long has Current Science been actively publishing? 
What is the publishing frequency of Current Science?
How many articles did Current Science publish last year?
What is the eISSN & pISSN for Current Science?
What is Citescore for Current Science?
What is SNIP score for Current Science?
Who is the publisher of Current Science?
